Market Overview:
The global arrhythmia management market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of arrhythmias, technological advancements in arrhythmia management devices, and rising geriatric population. The pacemakers segment is expected to account for the largest share of the global arrhythmia management market in 2018. This segment is projected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in this segment can be attributed to the increasing prevalence of heart failure and cardiac disorders, growing awareness about pacemakers among patients and healthcare professionals, and technological advancements in pacemaker devices. In terms of application, the hospitals segment is expected to account for the largest share of the global arrhythmia management market in 2018.
Product Definition:
Arrhythmia Management is the process of treating arrhythmias, which are abnormal heart rhythms. Arrhythmia Management is important because it can help to maintain a normal heart rhythm and prevent serious health complications.
Pacemakers:
Pacemakers are external devices that are implanted in the patient's body to restore the normal sinus rhythm. The most common indication for pacemaker implantation is heart blockage or heart failure. Pacemakers can also be used in cases of arrhythmias, where a person has an abnormal heartbeat and cannot achieve a regular rhythm by self-administration of medications or through lifestyle changes.
Defibrillators:
Defibrillators and it's usage in Arrhythmia Management market is a device used to restore the electrical activity of the heart after it has stopped pumping blood. It consists of two parts-a battery powered external device connected to an implanted defibrillator, and an implanted monitor that provides real time information about the state of cardiac function.
Application Insights:
The hospitals segment dominated the global arrhythmia management market in 2017 and is expected to maintain its lead over the forecast period. This can be attributed to factors such as availability of advanced healthcare facilities, highly skilled staff, and a large number of patients suffering from arrhythmia across the globe. As per estimates by WHO, around 35% of deaths occur due to cardiovascular diseases globally; out of which almost 60% take place in low-income countries. Thus, increasing prevalence rates coupled with rising awareness about arrhythmias will drive demand for devices & therapies across the world during this forecast period.
The ambulatory surgical centers (ASCs) segment is expected to register a significant CAGR over the forecast period owing to factors such as growing awareness among individuals regarding early diagnosis.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable healthcare policies, increasing geriatric population, and technological advancements. Moreover, an increase in the number of FDA approvals for pacemakers and implantable cardioverter-defibrillator has also contributed to regional growth. Europe accounted for a significant share due to high demand from countries such as Germany and France. The presence of regulatory authorities that monitor quality standards is also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to grow at a lucrative rate during the forecast period due to rising disposable income coupled with growing awareness about arrhythmia management devices among patients. Furthermore, improving healthcare infrastructure will further boost industry expansion opportunities in this region over next eight years time span.
Growth Factors:
- Increasing incidence of arrhythmia
- Growing geriatric population
- Rising prevalence of lifestyle diseases such as obesity and diabetes mellitus
- Technological advancements in arrhythmia management devices and therapies
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Arrhythmia Management Market Research Report
By Type
Pacemakers, Defibrillators, Ablation Devices
By Application
Hospitals, Ambulatory Surgical Centers, Clinics
By Companies
Medtronic, Boston Scientific, Abbott, Stryker, Biosense Webster, Philips Healthcare, Biotronik, Cardiac Science Corporation, Mortara Instrument, Livanova PLC, Medtronic, MicroPort Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Arrhythmia Management Market Report Segments:
The global Arrhythmia Management market is segmented on the basis of:
Types
Pacemakers, Defibrillators, Ablation Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Abbott
- Stryker
- Biosense Webster
- Philips Healthcare
- Biotronik
- Cardiac Science Corporation
- Mortara Instrument
- Livanova PLC
- Medtronic
- MicroPort Scientific
Highlights of The Arrhythmia Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pacemakers
- Defibrillators
- Ablation Devices
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Arrhythmia Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Arrhythmia management is the process of managing arrhythmias. This includes identifying and treating any underlying causes, as well as preventing future arrhythmias. Arrhythmia management may also include lifestyle changes, medications, or surgery.
Some of the major companies in the arrhythmia management market are Medtronic, Boston Scientific, Abbott, Stryker, Biosense Webster, Philips Healthcare, Biotronik, Cardiac Science Corporation, Mortara Instrument, Livanova PLC, Medtronic, MicroPort Scientific.
The arrhythmia management market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Arrhythmia Management Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Arrhythmia Management Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Arrhythmia Management Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Arrhythmia Management Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Arrhythmia Management Market Size & Forecast, 2018-2028 4.5.1 Arrhythmia Management Market Size and Y-o-Y Growth 4.5.2 Arrhythmia Management Market Absolute $ Opportunity
Chapter 5 Global Arrhythmia Management Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Arrhythmia Management Market Size Forecast by Type
5.2.1 Pacemakers
5.2.2 Defibrillators
5.2.3 Ablation Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Arrhythmia Management Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Arrhythmia Management Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Arrhythmia Management Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Arrhythmia Management Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Arrhythmia Management Analysis and Forecast
9.1 Introduction
9.2 North America Arrhythmia Management Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Arrhythmia Management Market Size Forecast by Type
9.6.1 Pacemakers
9.6.2 Defibrillators
9.6.3 Ablation Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Arrhythmia Management Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Arrhythmia Management Analysis and Forecast
10.1 Introduction
10.2 Europe Arrhythmia Management Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Arrhythmia Management Market Size Forecast by Type
10.6.1 Pacemakers
10.6.2 Defibrillators
10.6.3 Ablation Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Arrhythmia Management Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Arrhythmia Management Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Arrhythmia Management Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Arrhythmia Management Market Size Forecast by Type
11.6.1 Pacemakers
11.6.2 Defibrillators
11.6.3 Ablation Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Arrhythmia Management Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Arrhythmia Management Analysis and Forecast
12.1 Introduction
12.2 Latin America Arrhythmia Management Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Arrhythmia Management Market Size Forecast by Type
12.6.1 Pacemakers
12.6.2 Defibrillators
12.6.3 Ablation Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Arrhythmia Management Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Arrhythmia Management Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Arrhythmia Management Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Arrhythmia Management Market Size Forecast by Type
13.6.1 Pacemakers
13.6.2 Defibrillators
13.6.3 Ablation Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Arrhythmia Management Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Arrhythmia Management Market: Competitive Dashboard
14.2 Global Arrhythmia Management Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Boston Scientific
14.3.3 Abbott
14.3.4 Stryker
14.3.5 Biosense Webster
14.3.6 Philips Healthcare
14.3.7 Biotronik
14.3.8 Cardiac Science Corporation
14.3.9 Mortara Instrument
14.3.10 Livanova PLC
14.3.11 Medtronic
14.3.12 MicroPort Scientific